ATE271384T1 - Arylnitron therapeutische mittel zur behandlung von entzündlichen darmerkrankungen - Google Patents

Arylnitron therapeutische mittel zur behandlung von entzündlichen darmerkrankungen

Info

Publication number
ATE271384T1
ATE271384T1 AT99922983T AT99922983T ATE271384T1 AT E271384 T1 ATE271384 T1 AT E271384T1 AT 99922983 T AT99922983 T AT 99922983T AT 99922983 T AT99922983 T AT 99922983T AT E271384 T1 ATE271384 T1 AT E271384T1
Authority
AT
Austria
Prior art keywords
treatment
inflammatory bowel
bowel disease
arylnitron
therapeutic agents
Prior art date
Application number
AT99922983T
Other languages
English (en)
Inventor
William D Flitter
William A Garland
Meerveld Beverly Greenwood-Van
Ian Irwin
Original Assignee
Renovis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovis Inc filed Critical Renovis Inc
Application granted granted Critical
Publication of ATE271384T1 publication Critical patent/ATE271384T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
AT99922983T 1998-05-19 1999-05-18 Arylnitron therapeutische mittel zur behandlung von entzündlichen darmerkrankungen ATE271384T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8596198P 1998-05-19 1998-05-19
PCT/US1999/010442 WO1999059576A1 (en) 1998-05-19 1999-05-18 Aryl nitrone therapeutics for the treatment of inflammatory bowel disease

Publications (1)

Publication Number Publication Date
ATE271384T1 true ATE271384T1 (de) 2004-08-15

Family

ID=22195102

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99922983T ATE271384T1 (de) 1998-05-19 1999-05-18 Arylnitron therapeutische mittel zur behandlung von entzündlichen darmerkrankungen

Country Status (11)

Country Link
EP (1) EP1077694B1 (de)
AT (1) ATE271384T1 (de)
AU (1) AU3985599A (de)
CA (1) CA2332462A1 (de)
DE (1) DE69918826T2 (de)
DK (1) DK1077694T3 (de)
ES (1) ES2224660T3 (de)
NZ (1) NZ508176A (de)
PT (1) PT1077694E (de)
SI (1) SI1077694T1 (de)
WO (1) WO1999059576A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6730700B2 (en) 1998-12-02 2004-05-04 Renovis, Inc. 3,4,5,-trisubstituted aryl nitrone compounds and pharmaceutical compositions containing the same
UA66401C2 (en) 1998-12-02 2004-05-17 Sentor Pharmaceuticals Inc 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical composition containing the same
US20050182060A1 (en) * 2004-02-13 2005-08-18 Kelly Michael G. 2-Substituted and 4-substituted aryl nitrone compounds
ES2395803B1 (es) * 2011-08-01 2013-12-19 Consejo Superior De Investigaciones Científicas (Csic) - 80% Quinolilnitronas

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036097A (en) * 1989-10-17 1991-07-30 Oklahoma Medical Research Foundation Phenylbutyl nitrone compositions and methods for prevention of gastric ulceration
ATE209908T1 (de) * 1991-06-18 2001-12-15 Oklahoma Med Res Found RADIKALFÄNGER (ßSPIN TRAPSß) ZUR BEHANDLUNG VON MIT OXIDATION VON LIPIDEN UND PROTEINEN VERBUNDENEN ERKRANKUNGEN
US5292746A (en) * 1991-09-12 1994-03-08 Merrell Dow Pharmaceuticals Inc. Cyclic nitrones, pharmaceutical compositions thereof and their use in treating shock
US5455272A (en) * 1993-10-22 1995-10-03 Oklahoma Medical Research Foundation Spin trap nitronyl hindered phenols
CN1219130A (zh) * 1996-04-23 1999-06-09 桑道药品有限会司 用于治疗眼部炎症的含硝酮化合物的组合物
US6046232A (en) * 1997-10-17 2000-04-04 Centaur Pharmaceuticals, Inc. α-aryl-N-alkylnitrones and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
EP1077694B1 (de) 2004-07-21
DK1077694T3 (da) 2004-11-22
NZ508176A (en) 2004-01-30
DE69918826T2 (de) 2004-12-02
CA2332462A1 (en) 1999-11-25
ES2224660T3 (es) 2005-03-01
DE69918826D1 (de) 2004-08-26
SI1077694T1 (en) 2004-10-31
AU3985599A (en) 1999-12-06
EP1077694A1 (de) 2001-02-28
PT1077694E (pt) 2004-12-31
WO1999059576A1 (en) 1999-11-25

Similar Documents

Publication Publication Date Title
ATE417602T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE60329316D1 (de) Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer
EA200900802A1 (ru) Способы и композиции для лечения амилоидных заболеваний
EA200600078A1 (ru) Способы и композиции для лечения амилоидных заболеваний
DE69807115T2 (de) Angiostatische verbindungen und zusammensetzungen zur behandlung des glc1a glaukoms
DK0468012T3 (da) 17beta-substituerede 4-aza-5alfa-androstan-3-on-derivater og fremgangsmåde til fremstilling deraf
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
ATE411026T1 (de) Mittel zur behandlung der alzheimer-krankheit
DE60123238D1 (de) Zusammensetzungen zur behandlung von autoimmunkrankheiten
ATE238792T1 (de) Verwendung von makroliden zur behandlung von glaukom
DE69519577D1 (de) Prednisolonmetasulfobenzoatzusammensetzung zur behandlung von entzündungserkrankung des darmes
ATE260282T1 (de) Aromatische ester von camptothecinen und verfahren zur behandlung von krebserkrankungen
DE69918972D1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
DE602004028574D1 (de) Zusammensetzungen und verfahren zur behandlung des reizdarmsyndroms und von nichtulzeröser dyspepsie
ATE312104T1 (de) Verbindungen zur behandlung von beeinträchtigten fundischen entspannung
DE60018704D1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
DE69905214T2 (de) Mittel zur Behandlung der Osteoporose
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus
DE602004021363D1 (de) Imidazotriazin verbindungen zur behandlung von krebserkrankungen
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
ATE271384T1 (de) Arylnitron therapeutische mittel zur behandlung von entzündlichen darmerkrankungen
DE60010934D1 (de) Medikamente geeignet zur Behandlung von proliferativen Erkrankungen
WO2001035951A3 (en) Aryl nitrone therapeutics and methods for treating inflammatory bowel disease

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1077694

Country of ref document: EP

REN Ceased due to non-payment of the annual fee